Search - tctmd.com

Displaying 201 - 220 of 334

Sort: Relevancy | Date

News Daily News

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Michael O'Riordan

February 13, 2020

News Daily News

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

Michael O'Riordan

January 31, 2020

News Daily News

European Regulators Approve First Transcatheter MV Replacement Device

Michael O'Riordan

January 30, 2020

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Conference News PCR London Valves 2019

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

News Conference News PCR London Valves 2019

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Michael O'Riordan

November 17, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Advertisement

MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR

Formal Shared Decision-Making Aid for TAVR Gets Mixed Reviews

European Regulators Approve First Transcatheter MV Replacement Device

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Two Small Series Support Role for Cerebral Protection in TAVR

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content